Urtica Sp. z o.o. secures contract for Pharmaceutical products - Delivery of the drug Tebentafusp 0.1 mg/0.5 ml for the treatment of eye melanoma from the National Health Fund drug program

Poland, Feb. 27 -- Poland based Urtica Sp. z o.o. has secured contract from Wojewodzki Szpital Zespolony w Elblagu for Pharmaceutical products - Delivery of the drug Tebentafusp 0.1 mg/0.5 ml for the treatment of eye melanoma from the National Health Fund drug program. The value of the contract is worth 486799200 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....